Barriers and Solutions to Expanding PrEP Uptake – Pharmacist Perspectives

Join 2 leading experts for an interactive webinar on the pharmacist perspective on barriers and solutions to pre-exposure prophylaxis uptake in key populations.


The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Discussion of Barriers and Solutions to PrEP Uptake in Key Populations:
    • Black and Hispanic/Latinx People
    • Cisgender Women
    • Transgender Women
    • Adolescents
    • People Who Inject Drugs
  • Question and Answer Session


Date / Time
Event Details


Program Director
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director

Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Eric K. Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist
LifeCare Clinic
Indiana University Health
Indianapolis, Indiana

Neha Pandit, PharmD, AAHIVP, BCPS

Department of Pharmacy Practice and Science
University of Maryland Baltimore School of Pharmacy
Clinical Pharmacist
University of Maryland Midtown THRIVE Program
Baltimore, Maryland

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens


CE Accreditation


This activity is jointly provided by ProCE, LLC, the Society of Infectious Disease Pharmacists (SIDP), and Clinical Care Options, LLC. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-202-L02-P has been assigned to this live application-based activity (initial release date 9/20/2022). This activity is approved for 1.0 contact hour (0.1 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.

ProCE, LLC and Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE and CCO policy. ProCE and CCO are committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.